NanoInk Imaging Develops Next-Generation Polymer-Coated Nanoparticles

NanoInk Imaging is pleased to announce the development of a new class of polymer-coated nanoparticles for short-wave infrared (SWIR) imaging. To date, the company’s work has focused on albumin-coated nanoparticles, which have performed well but are subject to signal quenching. The newly developed polymer-coated nanoparticles are approximately ten times brighter in vivo than the company’s earlier formulations, while maintaining non-toxicity and stability in preclinical models.

These nanoparticles can also be functionalized with tumor-specific targeting ligands, enabling precise detection of cancer cells. The increased brightness significantly enhances the sensitivity of NanoInk’s imaging technology, allowing for more reliable detection of smaller tumors as well as immune cells within the tumor microenvironment. This advancement marks an important step in expanding the clinical and research applications of NanoInk’s imaging platform.